Home NDC 70301-2011 Temozolomide
Product NDC 70301-2011
11-digit product format 703012011
Labeler code 70301
Product ID 70301-2011_579d8af9-1f6e-362a-e063-6394a90aba17
Type HUMAN PRESCRIPTION DRUG
Nonproprietary name TEMOZOLOMIDE
Dosage form CAPSULE
Route ORAL
Labeler OPKO Pharmaceuticals, LLC
Application ANDA203898
Marketing category ANDA
Marketing start 2026-07-31
Substance TEMOZOLOMIDE
Active strength 250 mg/1
Pharmacologic classes Alkylating Activity [MoA]; Alkylating Drug [EPC]
Listing certified through 2027-12-31
Current FDA listing Yes Source provenance: Browse the complete Orange Book source catalog · source snapshot 1 .
Orange Book products# Current product rows page 1 of 1 · 6 matching rows.
Application-product, Trade name, Ingredient table Application-product Trade name Ingredient Strength Dosage form / route TE codes RLD / RS Approval date A203898-001 TEMOZOLOMIDE TEMOZOLOMIDE 5MG CAPSULE / ORAL 2016-02-10 A203898-002 TEMOZOLOMIDE TEMOZOLOMIDE 20MG CAPSULE / ORAL 2016-02-10 A203898-003 TEMOZOLOMIDE TEMOZOLOMIDE 100MG CAPSULE / ORAL AB 2016-02-10 A203898-004 TEMOZOLOMIDE TEMOZOLOMIDE 140MG CAPSULE / ORAL AB 2016-02-10 A203898-005 TEMOZOLOMIDE TEMOZOLOMIDE 180MG CAPSULE / ORAL AB 2016-02-10 A203898-006 TEMOZOLOMIDE TEMOZOLOMIDE 250MG CAPSULE / ORAL AB 2016-02-10
Therapeutic equivalence codes# Current TE-code rows page 1 of 1 · 4 matching rows.
Observed Orange Book product history# Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
Product history page 1 of 7 · 246 observed states.
Captured, Edition, Application-product table Captured Edition Application-product Trade name Strength Dosage form / route Product TE source text RLD / RS Approval date Source SHA-256 2026-02-19 14:30 UTC 2026-02 A203898-001 TEMOZOLOMIDE 5MG CAPSULE / ORAL 2016-02-10 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 A203898-002 TEMOZOLOMIDE 20MG CAPSULE / ORAL 2016-02-10 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 A203898-003 TEMOZOLOMIDE 100MG CAPSULE / ORAL AB 2016-02-10 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 A203898-004 TEMOZOLOMIDE 140MG CAPSULE / ORAL AB 2016-02-10 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 A203898-005 TEMOZOLOMIDE 180MG CAPSULE / ORAL AB 2016-02-10 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 A203898-006 TEMOZOLOMIDE 250MG CAPSULE / ORAL AB 2016-02-10 011fe1cb6892…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 A203898-001 TEMOZOLOMIDE 5MG CAPSULE / ORAL 2016-02-10 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 A203898-002 TEMOZOLOMIDE 20MG CAPSULE / ORAL 2016-02-10 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 A203898-003 TEMOZOLOMIDE 100MG CAPSULE / ORAL AB 2016-02-10 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 A203898-004 TEMOZOLOMIDE 140MG CAPSULE / ORAL AB 2016-02-10 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 A203898-005 TEMOZOLOMIDE 180MG CAPSULE / ORAL AB 2016-02-10 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 A203898-006 TEMOZOLOMIDE 250MG CAPSULE / ORAL AB 2016-02-10 31067a03dcf5…2025-08-23 18:47 UTC 2025-08 A203898-001 TEMOZOLOMIDE 5MG CAPSULE / ORAL 2016-02-10 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 A203898-002 TEMOZOLOMIDE 20MG CAPSULE / ORAL 2016-02-10 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 A203898-003 TEMOZOLOMIDE 100MG CAPSULE / ORAL AB 2016-02-10 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 A203898-004 TEMOZOLOMIDE 140MG CAPSULE / ORAL AB 2016-02-10 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 A203898-005 TEMOZOLOMIDE 180MG CAPSULE / ORAL AB 2016-02-10 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 A203898-006 TEMOZOLOMIDE 250MG CAPSULE / ORAL AB 2016-02-10 6a471c1ec25d…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 A203898-001 TEMOZOLOMIDE 5MG CAPSULE / ORAL 2016-02-10 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 A203898-002 TEMOZOLOMIDE 20MG CAPSULE / ORAL 2016-02-10 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 A203898-003 TEMOZOLOMIDE 100MG CAPSULE / ORAL 2016-02-10 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 A203898-004 TEMOZOLOMIDE 140MG CAPSULE / ORAL 2016-02-10 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 A203898-005 TEMOZOLOMIDE 180MG CAPSULE / ORAL 2016-02-10 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 A203898-006 TEMOZOLOMIDE 250MG CAPSULE / ORAL 2016-02-10 fd3edfee7708…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 A203898-001 TEMOZOLOMIDE 5MG CAPSULE / ORAL 2016-02-10 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 A203898-002 TEMOZOLOMIDE 20MG CAPSULE / ORAL 2016-02-10 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 A203898-003 TEMOZOLOMIDE 100MG CAPSULE / ORAL 2016-02-10 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 A203898-004 TEMOZOLOMIDE 140MG CAPSULE / ORAL 2016-02-10 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 A203898-005 TEMOZOLOMIDE 180MG CAPSULE / ORAL 2016-02-10 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 A203898-006 TEMOZOLOMIDE 250MG CAPSULE / ORAL 2016-02-10 b8a1b40f171c…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 A203898-001 TEMOZOLOMIDE 5MG CAPSULE / ORAL 2016-02-10 03ed91905a0d…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 A203898-002 TEMOZOLOMIDE 20MG CAPSULE / ORAL 2016-02-10 03ed91905a0d…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 A203898-003 TEMOZOLOMIDE 100MG CAPSULE / ORAL 2016-02-10 03ed91905a0d…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 A203898-004 TEMOZOLOMIDE 140MG CAPSULE / ORAL 2016-02-10 03ed91905a0d…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 A203898-005 TEMOZOLOMIDE 180MG CAPSULE / ORAL 2016-02-10 03ed91905a0d…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 A203898-006 TEMOZOLOMIDE 250MG CAPSULE / ORAL 2016-02-10 03ed91905a0d…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 A203898-001 TEMOZOLOMIDE 5MG CAPSULE / ORAL 2016-02-10 2680178bc6a6…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 A203898-002 TEMOZOLOMIDE 20MG CAPSULE / ORAL 2016-02-10 2680178bc6a6…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 A203898-003 TEMOZOLOMIDE 100MG CAPSULE / ORAL 2016-02-10 2680178bc6a6…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 A203898-004 TEMOZOLOMIDE 140MG CAPSULE / ORAL 2016-02-10 2680178bc6a6…
Observed Orange Book normalized TE history# Additional Listing Data#
Finished product Yes
Brand name base Temozolomide
Listing expiration 2027-12-31 Active Ingredients# Ingredient, Strength table Ingredient Strength TEMOZOLOMIDE 250 mg/1
Harmonized UNII identifiers# UNII identifiers page 1 of 1 · 1 matching rows.
Identifier, FDA.report destination table Identifier FDA.report destination YF1K15M17Y Internal UNII lookup
Harmonized SPL set identifiers# SPL set identifiers page 1 of 1 · 1 matching rows.
DailyMed Product Concepts# DailyMed Package Descriptions# Package NDC, Product, Description table Package NDC Product Description Form Quantity Strength SPL version 70301-2011-1 Temozolomide 1 in 1 PACKET CAPSULE 1 1 70301-2011-1 Temozolomide 5 in 1 CARTON CAPSULE 5 1
openFDA label cross-check# OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
Matched openFDA labels page 1 of 1 · 4 matching rows.
Brand, Generic, Manufacturer table Brand Generic Manufacturer SPL set ID Effective date Available safety fields Join Temozolomide TEMOZOLOMIDE OPKO Pharmaceuticals, LLC 9dff10ec-6a55-47b6-a458-b7c39e32dc55 2026-07-27 Warnings, Adverse reactions Exact identifier application applno (ANDA): 203898 application number: ANDA203898 Temozolomide TEMOZOLOMIDE OPKO Pharmaceuticals, LLC f6d762ea-fff0-43e8-b67d-bef19e883dd8 2026-07-27 Warnings, Adverse reactions Exact identifier application applno (ANDA): 203898 application number: ANDA203898 Temozolomide TEMOZOLOMIDE OPKO Pharmaceuticals, LLC f743f7e0-74cf-47e5-bf21-f2b75d2596dc 2026-07-27 Warnings, Adverse reactions Exact identifier application applno (ANDA): 203898 application number: ANDA203898 Temozolomide TEMOZOLOMIDE OPKO Pharmaceuticals, LLC b3f69c67-db30-4266-8075-9b18c71c9fc1 2026-07-27 Warnings, Adverse reactions Exact identifier application applno (ANDA): 203898 application number: ANDA203898 ndc (product): 70301-2011
DailyMed RxNorm Mappings# Packages# Package NDC, 11-digit format, Description table Package NDC 11-digit format Description Units Marketing start Sample Status 70301-2011-1 70301201101 5 PACKET in 1 CARTON (70301-2011-1) / 1 CAPSULE in 1 PACKET 5 packet 2026-07-31 0 Current